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Abstract
Background: Candida albicans is a diploid pathogenic fungus not yet amenable to routine genetic
investigations. Understanding aspects of the regulation of its biological functions and the assembly
of its protein complexes would lead to further insight into the biology of this common disease-
causing microbial agent.
Results:  We have developed a toolbox allowing in vivo protein tagging by PCR-mediated
homologous recombination with TAP, HA and MYC tags. The transformation cassettes were
designed to accommodate a common set of integration primers. The tagged proteins can be used
to perform tandem affinity purification (TAP) or chromatin immunoprecipitation coupled with
microarray analysis (ChIP-CHIP). Tandem affinity purification of C. albicans Nop1 revealed the high
conservation of the small processome composition in yeasts. Data obtained with in vivo TAP-tagged
Tbf1, Cbf1 and Mcm1 recapitulates previously published genome-wide location profiling by ChIP-
CHIP. We also designed a new reporter system for in vivo analysis of transcriptional activity of gene
loci in C. albicans.
Conclusion: This toolbox provides a basic setup to perform purification of protein complexes and
increase the number of annotated transcriptional regulators and genetic circuits in C. albicans.
Background
Candida albicans is an important human fungal pathogen
because of its clinical significance as well as its use as an
experimental model for scientific investigation [1]. This
opportunistic pathogen is a natural component of the
human skin, gastrointestinal and genitourinary flora, but
it can sporadically cause a variety of infections. Although
many  Candida  infections are not life-threatening (oral
thrush and vaginal candidiasis, for example), immuno-
suppressed patients can be subjected to potentially lethal
systemic infections, and therefore Candida infections are a
major public health concern [2,3]. C. albicans can also col-
onize various biomaterials, and readily forms dense, com-
plex biofilms that are resistant to most antifungal agents.
Because of the challenges of drug resistance [4] and the
eukaryotic nature of C. albicans that makes it similar to its
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human host, extensive efforts are underway to identify
new drug targets for therapeutic intervention; many of
these take advantage of tools from the genomic era [5-7].
Because of some of its unique biological features, C. albi-
cans is also becoming attractive to studies of more funda-
mental aspects of genome maintenance, regulatory
biology and morphogenesis [8-10].
The diploid nature and the absence of a complete sexual
cycle in C. albicans reduces the ease with which genetic
manipulations can be achieved [11]. Therefore, biochem-
ical, cell biological and genomic analyses of gene products
provide alternate strategies to improve our understanding
of this pathogen. In particular, obtaining a better insight
into how specific protein complexes assemble in C. albi-
cans would help define targets for drug development. For
example, the large-scale definition of protein complexes
by tandem affinity purification (TAP), as it was previously
done in S. cerevisiae [12,13], should reveal the architecture
of biochemical networks and protein machines specific to
C. albicans. This approach would also give insight into the
evolution of protein complexes in ascomycetes. As well,
the availability of tools allowing comprehensive func-
tional analysis of transcription factors (TFs) on a genome-
wide scale could enhance cellular studies. Genome-wide
location analysis, or ChIP-CHIP analysis (chromatin
immunoprecipitation (ChIP) followed by DNA microar-
rays (CHIP)) allows the identification of direct targets of a
defined TF on a genomic scale [14]. This approach has
been comprehensively applied to the model budding
yeast S. cerevisiae in order to map its transcriptional regu-
latory network [15,16]. While first developed in S. cerevi-
siae, ChIP-CHIP has since been applied to other
organisms including C. albicans [17,18]. In addition, C.
albicans  has recently been established as an interesting
model organism for the study of the evolution of tran-
scriptional regulatory networks. In fact, it appears that C.
albicans differs significantly in its mode of gene regulation
from the well-characterized S. cerevisiae transcriptional
circuits. It has recently served as a comparative system for
studying the evolution of the mating type control circuit
and the evolution of ribosomal protein (RP) regulation
[19,20]. Furthermore, changes occuring in the activity of
TFs seem to account for part of acquired drug resistance in
C. albicans [21,22]. Moreover, several TFs play a critical
role in the C. albicans morphological transitions and in
biofilm formation [10,23]. Therefore, a detailed under-
standing of the transcriptional regulation mechanisms in
C. albicans would be valuable for basic research purposes
as well as for improving our understanding of drug resist-
ance and for aiding in the development of new antifun-
gals.
Here we report the construction of a new set of PCR-based
epitope-tagging vectors for C. albicans that is successfully
applied to perform a biochemical characterization of the
small processome subunit via Nop1 tandem affinity puri-
fication as well as genome-wide location analysis of the
model TFs Tbf1, Cbf1 and Mcm1.
Results and discussion
A set of PCR cassettes for protein tagging
The choice of selectable marker genes in our cassettes,
URA3, HIS1 and ARG4 was guided by the availability of
the C. albicans strains BWP17 and SN76 that have the aux-
otrophic mutations (ura3/ura3;  his1/his1;  arg4/
arg4)[24,25]. Our cassettes permit the use of a single 120-
bp primer pair (20 bp of vector sequences and 100 bp
from the gene to be tagged) to tag genes with three
epitopes (Fig. 1A). In addition, our PCR strategy is com-
patible with the previously published pFA-XFP-tagging
system [26]. With this vector set, the tagged protein is
expressed under the control of its own regulatory
sequences and chromatin environment and thus at its
normal physiological levels, thereby maximizing the bio-
logical relevance of biochemical analyses.
The HA and MYC epitope tags have been used to tag pro-
teins in various organisms and for various applications
[27,28]. They represent highly immunogenic peptides
with little biological activity that can then be used in
immunoprecipitation/co-immunoprecipitation experi-
ments to validate protein complex formation. The TAP tag
was more recently developed in order to obtain high puri-
fied protein samples for mass spectrometry analysis of
protein complexes [29]. Tagged strains were first validated
by PCR and subsequently by western blotting (Fig. 2A and
2B), and we confirmed that the tagged constructs are eas-
ily immunoprecipitated (data not shown). Doubly tagged
strains can also be obtained with combinations of selec-
tive markers offered by the BWP17 and the SN76 strain
backgrounds. We produced Tbf1-HA/Cbf1-Myc and recip-
rocal tagged stains (Fig. 2C).
Tandem affinity purification of Nop1
Since its introduction in 1999, the TAP-tag has been used
in various organisms to perform protein-complex purifi-
cations [29]. In S. cerevisiae, it has been used to assess pro-
tein-protein interactions on a large scale [12,30]. We
performed a standard TAP procedure using the TAP-
tagged Nop1, a component of the small processome sub-
unit in S. cerevisiae [13]. Mass spectrometric analysis of in-
solution digested TCA-precipitated proteins after the TAP
procedure identified 18 C. albicans proteins and in-gel
digestion of four SYPRO Ruby stained SDS-PAGE bands
led to the identification of an additional protein (Fig. 2D
and Table 1). In total, 19 C. albicans proteins were identi-
fied, 16 of which are bona fide components of the S. cere-
visiae  small sub-unit processome (SSU processome)
(Table 1 and Fig. 2E) [13]. In addition, three ribosomalBMC Genomics 2008, 9:578 http://www.biomedcentral.com/1471-2164/9/578
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Plasmid constructs for in vivo protein tagging in C. albicans Figure 1
Plasmid constructs for in vivo protein tagging in C. albicans. A) Two-step insertion of tags by 1- PCR and 2- homolo-
gous recombination. B) PCR confirmation of tagged constructs. YFG stands for Your Favorite Gene.
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proteins were co-purified with Nop1; ribosomal proteins
are common false positives in protein complex purifica-
tion procedures (Table 1)[31]. We compared the coverage
generated through our approach to that of the ortholo-
gous Nop1-TAP purification in S. cerevisiae. The C. albicans
Nop1-TAP bait retrieved 16 proteins (33%) of the anno-
tated SSU processome subunits while its S. cerevisiae
ortholog retrieved 24 (50%) http://www.thebiogrid.org/
SearchResults/summary/32040, so the coverage of the S.
cerevisiae set was higher. However, the proportion of core
components of the SSU processome retrieved in C. albi-
cans (84%) surpasses the proportion retrieved in S. cerevi-
siae by all published affinity-capture followed by mass
spectrometry studies (37%)[32]. It is likely that the strin-
gency of our protocol accounts for the lower coverage and
higher specificity of the set of hits retrieved; Modifications
of the purification conditions could allow for the desired
specificity. Overall, it is apparent that a basic TAP protocol
is amenable to C. albicans proteins. This approach will be
of great utility in the analysis of function of currently
poorly defined proteins and in the study of the evolution
of protein complexes in yeasts.
ChIP-CHIP analysis of in vivo tagged transcription factors
One potential application of TAP-tagged TFs consists of
their use in ChIP-CHIP to map their DNA-binding targets
in vivo. ChIP-CHIP was therefore performed for three TAP-
tagged TFs; Tbf1, Cbf1 and Mcm1. For Tbf1 and Cbf1, the
results obtained were compared to previously published
data using ectopically expressed Tbf1-HA and Cbf1-HA
constructs [20]. The location profiles of TAP-tagged TFs
were essentially identical to the previous results and con-
firmed that the RP regulon is dominated by the Myb tran-
scription factor Tbf1 working in conjunction with Cbf1
(Fig. 3A and 3B) [20].
Genome-wide location of the S. cerevisae MADS box cell
cycle regulator ortholog Mcm1 was also investigated in C.
albicans cells. S. cerevisiae Mcm1 plays a critical role in the
regulation of cell cycle transitions and, more specifically,
Our new PCR tagging cassettes allow the rapid biochemical analysis of tagged proteins Figure 2
Our new PCR tagging cassettes allow the rapid biochemical analysis of tagged proteins. PCR (A) and Western 
blot (B) confirmation of TAP, Myc and HA-tagged transcription factors Cbf1 and Tbf1. C) Western blot validation of doubly 
tagged strains Cbf1-HA/Tbf1-Myc and Cbf1-Myc/Tbf1-HA. D) SYPRO Ruby stained SDS-PAGE gel following tandem affinity 
purification of Nop1-TAP. Proteins identified in each band by in-gel digestion followed by mass spectrometry are identified on 
the left. E) Venn diagram comparison of Nop1-TAP hits in C. albicans and S. cerevisiae.
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Table 1: Mass spectrometry results after Nop1-TAP tandem affinity purification
Systematic 
name
Common 
name
Protein Score Number of 
peptides*
Mass (kDa) Cellular 
component
Biological 
process
Molecular 
function
orf19.7569 Sik1 504.3 8 58 small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.1566 Utp21 337.4 7 104 Small-subunit 
processome
rRNA 
modification
Unknown
orf19.1199 Nop5 327.5 6 57 Small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.7154 Utp18 208.3 4 62 Small-subunit 
processome
rRNA 
modification
Unknown
orf19.1633 Utp4 206.5 4 85 Small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.3138 Nop1* 186.5 3 33 Small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.7599 Utp5 174.3 4 71 Small-subunit 
processome
rRNA 
modification
Unknown
orf19.3609 Utp15 172.8 2 47 Small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.6710 Utp9 149.8 1 50 Small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.1601 Rpl3 121.4 2 44 Cytosolic large 
ribosomal 
subunit
translation structural 
constituent of 
ribosome
orf19.3430 Bud21 100.9 2 25 Small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.3276 Pwp2 99.7 2 104 Small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.2688 Nan1 88.7 2 94 Small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.5436 Utp8 88.5 1 81 Small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.5106 Dip2 77.8 2 110 small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.5225.2 Rpl27 59.7 1 16 cytosolic large 
ribosomal 
subunit
translation structural 
constituent of 
ribosome
orf19.2830 Rrp9 58.8 1 62 small-subunit 
processome
rRNA 
modification
snoRNA binding
orf19.6085 Rpl16 56.9 1 20 cytosolic large 
ribosomal 
subunit
translation structural 
constituent of 
ribosome
orf19.4268 Utp13** NA NA 90 small-subunit 
processome
rRNA 
modification
snoRNA binding
* Nop1 was the bait in this tandem affinity purification experiment.
** Utp13 was identified by in-gel but not in-solution digestion.BMC Genomics 2008, 9:578 http://www.biomedcentral.com/1471-2164/9/578
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of the pre-replication complex (Pre-RC). The Mcm1 para-
log Arg80 arose after the whole-genome duplication of the
yeast lineage and is involved in the regulation of arginine
metabolism genes [8]. The overlap of our Mcm1 genome-
wide binding data in yeast state cells with a previously
published Mcm1 ChIP-CHIP done on tiling microarrays is
highly significant (pvalue = 2.7E-11) with 198 genes com-
mon between studies [8] (Fig. 3D). We confirm that C.
albicans Mcm1 occupies the roles of S. cerevisiae Mcm1
and Arg80 since genes from the arginine biosynthesis
pathway such as ARG3/4/5–6/8, CAR1 and the zinc tran-
scription factor ARG81 are enriched in our set (pvalue =
5.52E-07; Table 2). Genes involved in the biosynthesis of
the other basic amino acid, lysine (LYS1/9/21/22  and
144), and also catabolic proline processing (PUT1 and 2)
are also enriched in ours and Tuch et al. (2008) gene lists
(Table 2). In addition, we confirm that Mcm1 binds
strongly to its own promoter (Table 2). We finally confirm
Validation of the Cbf1, Tbf1 and Mcm1 TAP-tagged TFs by ChIP-CHIP analysis Figure 3
Validation of the Cbf1, Tbf1 and Mcm1 TAP-tagged TFs by ChIP-CHIP analysis. Tbf1-HA and Cbf1-HA ChIP-CHIP 
[20] overlaps Tbf1-TAP (A) and Cbf1-TAP (B) ChIP-CHIP performed with our in vivo tagged constructs. C) Comparison of 
Mcm1-TAP ChIP-CHIP conducted before and after the yeast to hyphal transition with the Mcm1 targets derived from Tuch et 
al. (2008) experiments highlighted. D) Comparison of the target genes of Mcm1-TAP in yeast and hyphal states and their over-
lap with Tuch et al. (2008) gene list.
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a previous study revealing that C. albicans Mcm1 regulates
MDR1  expression and thereby, drug resistance [8,33].
Indeed, a significant enrichment (7.49 fold) of Mcm1
binding to the promoter of the drug efflux facilitator gene
MDR1  was observed in both yeast and hyphal states.
However, our data diverges from the other Mcm1 ChIP-
CHIP publications at some points. First, our results show
Mcm1 binding in the promoters of almost all members of
the pre-replication complex (Pre-RC) (Mcm helicases
genes MCM2/3/4/5 and 7; pvalue = 1.87E-06; Table 2)
while the Tuch et al. (2008) data only uncovered two
members of this complex (MCM2 and 7). In addition, we
detected reproducible Mcm1 binding at two origin-recog-
nition-complex components (ORC1 and 3) and the load-
ing factor for the Mcm complex, CDC6  (Table 2; see
Additional file 1). Second, binding of the promoters of
the cyclin genes CLN3, HGC1 and CLB3 by Mcm1 was not
detected in our experimental setup (see Additional file 1
and 2). In total, 530 Mcm1 targets are uniquely found in
the Tuch et al. gene list [8](Fig. 3D). These major differ-
ences are likely due to variations between the two inde-
pendently conducted studies. Tuch and collaborators 1)
treated their cells with pheromone, 2) used a polyclonal
rabbit antiserum raised against an Mcm1 peptide, 3) used
signal ratios of cy5 labelled IP versus cy3 labelled whole-
cell extract prior to performing the IP and 4) used tiling
arrays to determine the promoter targets of Mcm1. Our
procedure is somewhat different: we 1) used YPD grown
cells, 2) used IgG beads-proteinA interaction to enrich tar-
get regions, 3) compared each experimental IP to a mock
IP performed in untagged cells and 4) used full genome
arrays with smaller coverage (about two probes/intergenic
region). All these experimental changes could affect to dif-
ferent degrees the final result of a ChIP-CHIP. First, treat-
ing cells with pheromone might dramatically alter Mcm1
binding at some point in the cell cycle and pheromone
response elements and deplete it at others (such as the
Mcm complex genes). Second, polyclonal anti-Mcm1
antibodies can have cross-specificities that would not be
corrected for by using the whole-cell extract as a control
instead of a mock IP or an IP performed with a preim-
mune serum. Third, the different resolutions of the two
studies could account for some overlooked targets in our
experiments.
We also performed Mcm1-TAP ChIP-CHIP in the yeast to
hyphal transition triggered by serum at 37°C. Mcm1 was
recruited to a limited set of genes (36) under these condi-
tions (Fig. 3D). Noticeably, it was enriched in the promot-
ers of ALS3, HWP1 and ECE1 after hyphal induction (see
Additional files 1 and 2).
Thus, our genome-wide location data showed a signifi-
cant consistency with previously published results on the
three TFs. This suggests that our chromosomally tagged
alleles are functional and that the use of a TAP-IgG pull-
down protocol is applicable for ChIP-CHIP as previously
reported in S. cerevisiae 26 and that this protocol is compa-
rable to a ChIP method based on a anti-HA (for Cbf1 and
Tbf1) or rabbit polyclonal (for Mcm1) antibody IP.
In vivo beta-galactosidase reporter assays
The beta-galactosidase reporter system described here has
already been applied to the problem of RP gene regulation
in Hogues et al (2008). It allows the integration of
reporter constructs in the actual chromatin environment
of the gene of interest. Here, we describe its usefulness in
the quantitative study of active gene loci. We produced
pLYS9-lacZ and pOPI3-lacZ strains and beta-galactosidase
reporter assays were performed with YPD grown cells. Our
results show variable levels of reporter activity across these
three promoters (Fig. 4). The multiple cloning site of our
pFA-lacZ-URA3 construct allows the easy creation of vari-
ous  cis-regulatory mutants as examplified by the the
pRPL11 promoter (pRPL11) [20].
Conclusion
Here, we have presented a new set of tools for functional
characterization of C. albicans gene products by biochem-
ical methods. We believe that the availability of such tools
will greatly help future understanding of the biology of
this important human pathogen.
Methods
Construction of chromosomal tagging PCR cassettes
We first adapted the S. cerevisiae PCR TAP-tagging vector
pEB1340 [34] for its use in C. albicans by substituting the
S. cerevisiae HIS3 marker with the C. albicans URA3, HIS1
and ARG4 genes from the previously published pFA-GFP
plasmid series [26] (Fig. 1A). Subcloning of the C. albicans
auxotrophic markers was done by ligation of AscI-PmeI
fragments in AscI-PmeI digested pEB1340. We then
derived triple HA or MYC epitope-tagging vectors in the
same pFA plasmid backbones by cloning oligonucleotides
encoding the HA or MYC epitope tags and containing
XmaI and AscI sites (Table 3) between the XmaI and AscI
sites of the pEB1340 plasmid. Auxotrophic markers
URA3, HIS1 and ARG4 from plasmids pFA-XFP [26] were
then subcloned into the HA and Myc constructs between
AscI and PmeI.
The beta-galactosidase reporter was constructed by sub-
cloning a PstI-MluI fragment corresponding to the Strepto-
coccus thermophilus lacZ ORF from plasmid placpoly [35]
between the PstI and AscI sites of plasmid pFA-XFP-URA3
[26].
PCR reactions were performed in 50-μl volumes contain-
ing 1 ng of plasmid template with the Expand Long Tem-BMC Genomics 2008, 9:578 http://www.biomedcentral.com/1471-2164/9/578
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Table 2: Mcm1-TAP targets in ChIP-CHIP analysis
Systematic name Common name Function Fold enrichment
Arginine metabolism
orf19.5610 ARG3* Ornithine carbamoyl-transferase 2.20
orf19.4788 ARG5,6 Acetylglutamate kinase 3.24
orf19.3770 ARG8* Acetylornithine aminotransferase 5.18
orf19.2077 ARG81* Zinc-finger TF 3.08
orf19.3934 CAR1 Arginase 3.82
orf19.3221 CPA2* Carbamoyl phosphate synthetase 2.58
Lysine metabolism
orf19.1789.1 LYS1* Saccharopine dehydrogenase 5.00
orf19.7448 LYS9* Saccharopine dehydrogenase 2.27
orf19.772 LYS21 Homocitrate synthase 2.58
orf19.4506 LYS22 Homocitrate synthase 2.57
orf19.5380 LYS144* Zinc cluster TF 2.78
Proline catabolism
orf19.4274 PUT1* Proline dehydrogenase 5.01
orf19.3974 PUT2* 1-pyrroline-5-carboxylate dehydrogenase 2.78
Drug resistance
orf19.5604 MDR1 ABC transporter
Mcm complex
orf19.7025 MCM1* MADS box TF 5.59
orf19.4354 MCM2* ATP-dependent DNA helicase 3.65
orf19.1901 MCM3 ATP-dependent DNA helicase 4.1
orf19.3761 MCM4 ATP-dependent DNA helicase 3.28
orf19.5487 MCM5 ATP-dependent DNA helicase 2.95
orf19.201 MCM7* ATP-dependent DNA helicase 3.87
Mcm complex loading
orf19.5242 CDC6* ATPase helicase clamp loader 1.79
Origin recognition complex (ORC)
orf19.3000 ORC1 ATPase for DNA binding 1.67
orf19.6942 ORC3 ATPase 1.81
* Genes in common with ChIP-CHIP data of Tuch et al., (2008) using tiling array.BMC Genomics 2008, 9:578 http://www.biomedcentral.com/1471-2164/9/578
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plate polymerase following manufacturer's instructions
(Roche, Germany). PCR parameters were 1 cycle at 94°C,
5 min followed by 35 cycles at 94°C, 30 sec; 58°C, 1 min;
68°C, 3 min.
Construction of C. albicans epitope-tagged strains
Cell growth, transformation, and DNA preparation were
carried out using standard procedures [26,36]. Transform-
ants were selected on either of -Ura, -His or -Arg selective
plates. Correct integration was verified by PCR, sequenc-
ing and finally Western blotting (Fig. 1A). Rate of correct
integration was comparable to a previous study using sim-
A new reporter construct allowing in vivo analysis of gene expression in C. albicans Figure 4
A new reporter construct allowingin vivo analysis of gene expression inC. albicans. A) Gene replacement by beta-
galactosidase following 1- wild-type or mutant promoter cloning, 2- PCR amplification of the promoter-lacZ fusion and 3- in 
vivo gene replacement by transformation and homologous recombination. B) PCR confirmation of our in vivo inserted beta-
galactosidase constructs. C) Beta-galactosidase activity of the promoters of the OPI3, LYS9 and RPL11 genes. YFG stands for 
Your Favorite Gene.
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Table 3: Primers used for in this study
Name Sequence
HA_F CCGGGTACCCATACGATGTTCCTGACTATGCGGGCTATCCCTATGACGTCCCGGACTATGCAGGATATCCATATGACGTTCC
AGATTACGCTTAGGG
HA_R CGCGCCCTAAGCGTAATCTGGAACGTCATATGGATATCCTGCATAGTCCGGGACGTCATAGGGATAGCCCGCATAGTCAGGA
ACATCGTATGGGTAC
5MYC_F CCGGGGAACAGAAGCTTATATCCGAAGAAGACCTCGGAGAGCAAAAGCTCATTTCAGAAGAGGATCTAGGCGAACAGAAAC
TAATCTCGGAGGAGGACCTCGGTGAACAAAAGCTTATCTCTGAGGAAGATCTTGGCGAGCAGAAGCTCATATCAGAGGAAGA
CCTAGGG TAG GG
5MYC_R CGCGCCCTACCCTAGGTCTTCCTCTGATATGAGCTTCTGCTCGCCAAGATCTTCCTCAGAGATAAGCTTTTGTTCACCGAGGT
CCTCCTCCGAGATTAGTTTCTGTTCGCCTAGATCCTCTTCTGAAATGAGCTTTTGCTCTCCGAGGTCTTCTTCGGATATAAGC
TTCTGTTCC
Nop1-TAP_F AGAAGAAAGAATTAAACCATTGGAACAATTGACCTTGGAACCTTATGAAAGAGACCATTGTATTGTTGTTGGTAGATACATGA
GAAGCGGAATAAAGAAAGGT CGA CGG ATC CCC GGG TT
Nop1-TAP_R TAGAGTTGATTAGACCTTATTGTTTTATTTTTCATTTTATTATATATGTCGTATCTTACAGTTCTTTAAATACCAGTGTTTCCAAA
ATTTTCATTCATTCTCG ATG AAT TCG AGC TCG TT
Cbf1-TAP_F TGAACAAGCTGTTAGTGAATTGAGTGCTTCAAATGAGAAATTGAAACATGAATTAGAATCAGCTTATCGTGAAATCGAACAATT
GAAGAGAGGGAAGAAAGGT CGA CGG ATC CCC GGG TT
Cbf1-TAP_R TAACATAATTTCAAATACCGAGTAGGAATACACAACCCCAACATCTAACCAGCCATACATTTACATATTTATAATTACATATTA
AAACATCGTCAAATTAATCG ATG AAT TCG AGC TCG TT
Tbf1-TAP_F AACAACAAGAGAAAGAACAACCGGATCAGCAACAACCAGATCAACAACACCCAGATCGACAACAACAAGAGCAGATCCAAC
AACCAGAAAATCTGGATAAAGGT CGA CGG ATC CCC GGG TT
Tbf1-TAP_R ATCAACTATTGTGATCCTGCTTAAGTTAGCTTGAACAATTATTCAAATCAATTTACACCTTAAAGATAGATTAATTAACAATACA
AATATAATGCTACATGTCG ATG AAT TCG AGC TCG TT
Mcm1-TAP_F ACATCAACCTGGTATTCCATTACAAGGTGGTTATAGTGATCAATACCTGTATTTTGGTAATATTCAAAATAACAACATACCTAA
TCAACAGCAATATCAAGGTCGACGGATCCCCGGGTT
Mcm1-TAP_R ATTATTCACCTAAATCCCCTGACCTCTGGCCAAACACTTTCTTTGTAGATGGGAGGGGAGCGGGGGGAGGAAATGAAAAACC
ATTGGCAACGAGAAAAAGATCGATGAATTCGAGCTCGTT
Nop1_confirm_F AATCATAGATGATGCTAGACATCC
Nop1_confirm_R TGTTGGGTCTAAAGGTCAAAGTGC
Cbf1_confirm_F AAGAGAATCCATAAATACTGG
Cbf1_confirm_R CTTTGATACCCCTAATGTTTC
Tbf1_confirm_F AAGCGGTTTGGAAATTCCTAG
Tbf1_confirm_R TTGCATGTTAAAATTCGTCTC
Mcm1_confirm_F TGACGATGGTACTTCTCAAGGT
Mcm1_confirm_R AATTGTTTCAACATTTTGGTTTTT
TAP-HA_F GGT CGA CGG ATC CCC GGG TTA TAC CCA TAC GAT GTT CCT GAC
TAP-MYC_F GGT CGA CGG ATC CCC GGG TTA GAA CAG AAG CTT ATA TCC GAA
TAP-HA-MYC_R TCG ATG AAT TCG AGC TCG TTBMC Genomics 2008, 9:578 http://www.biomedcentral.com/1471-2164/9/578
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ilar condiitons and was in the range of 40–80% depend-
ing on the gene locus considered [26]. We used this
strategy to C-terminally fuse Tbf1, Cbf1 and Mcm1 with a
TAP tag and to introduce an HA or a MYC tag to the C-ter-
minus of Tbf1 and Cbf1.
Western blotting
Whole cell extracts were obtained by boiling cells at 2 ODs
in loading buffer with 100 mM DTT for 10 minutes. Pro-
teins were then separated on a 10% SDS-PAGE gel and
transferred to a PVDF membrane (Millipore). Antibodies
were prepared in TBS-0.05% Tween20 5% skim milk pow-
der. A rabbit polyclonal antibody directed against the
TAP-tag (Open Biosystems) was used at 0.5 μg/ml while
monoclonal antibodies anti-HA (12CA5) and anti-Myc
(9E10) were used at 5 μg/ml. HRP-conjugated goat anti-
rabbit and anti-mouse secondary antibodies (Santa Cruz)
were used at 0.04 μg/ml. The HRP signal was revealed
with Immobilon™ HRP substrate (Millipore).
TAP purifications and mass spectrometry
Tandem affinity purifications were performed as
described http://depts.washington.edu/yeastrc/pages/
plasmids.html and then precipitated with Trichloroacetic
acid (TCA). For mass spectrometry analysis of the TAP
purified proteins, the digestion was performed using
Trypsin (Promega) in 50 mM ammonium bicarbonate for
4 hours at 37°C and dried down. One quarter of the TCA
precipitate was loaded on a 10% SDS-PAGE gel. The gel
was stained with SYPRO Ruby according to manufac-
turer's instructions (Invitrogen). Excised protein bands
were processed as described [37]. Samples were resolubi-
lized in 5% acetonitrile 0.2% formic acid and analyzed on
a Eksigent nanoLC system coupled to a Thermo LTQ-
Orbitrap MS instrument with a home-made C18 pre-col-
umn (5 mm × 300 um) and an analytical column (10 cm
× mm × 300 m i.d. Jupiter 3 m C18). Sample injection was
10 ul. The digest was first loaded on the pre-column at a
flow rate of 4 ul/min and subsequently eluted onto the
analytical column using a gradient from 10% to 60%
aqueous acetonitrile (0.2% formic acid) over 56 min at
600 nl/min. Database searches were performed against a
non-redundant fungal database using Mascot version 2.1
(Matrix Science).
ChIP-CHIP analysis of Tbf1, Cbf1 and Mcm1by TAP-IgG 
pull-down in C. albicans
Chromatin immunoprecipitation (ChIP) experiments
were performed with chromosomally tagged Tbf1-TAP,
Cbf1-TAP and Mcm1-TAP as described [20]. Cells were
grown to an optical density at 600 nm of 0.6 in 50 ml of
YPD or YPD with 10% FBS for Mcm1-TAP in hyphal state.
We followed the ChIP protocol available at http://
www.ircm.qc.ca/microsites/francoisrobert/en/317.html
with the following exceptions: chromatin was sonicated
to an average 300 bp, and 700 μl of whole-cell extract
(WCE) were incubated with IgG-Sepharose beads (GE
Healthcare). Tagged ChIPs were labeled with Cy5 dye and
untagged (mock) ChIPs were labeled with Cy3 dye and
were then co-hybridized to our full-genome arrays.
Candida albicans full-genome arrays, hybridization, 
scanning and normalization
Our C. albicans full-genome microarrays contain single
spots of 5,423 intergenic 70-mer oligonucleotide probes
combined with 6,394 intragenic 70-mer oligonucleotide
probes already in use in our C. albicans ORF microarray
[20,38]. We designed the 5,423 probes that correspond to
the promoter regions of most of the genes in the C. albi-
cans Genome Assembly 21 by using the same algorithm
that was successfully applied to the development of our C.
albicans  ORF oligonucleotide arrays with added weight
provided for regions of high homology among Candida
species. Our lab has developed full-genome (ORF and
intergenic) arrays for use in location profiling experiments
and the DNA microarrays were processed and analysed as
previously described [20].
Nucleotide sequence accession numbers
The sequences of plasmids pFA-TAP-URA3, pFA-TAP-
HIS1, pFA-TAP-ARG4, pFA-HA-URA3, pFA-HA-HIS1,
pFA-HA-ARG4, pFA-MYC-URA3, pFA-MYC-HIS1, pFA-
MYC-ARG4 and pFA-LacZ-URA3 have been submitted to
GenBank and have been assigned the following accession
numbers: FJ160456, FJ160457, FJ160458, FJ160464,
FJ160462, FJ160463, FJ160460, FJ160461, FJ160459 and
FJ160455, respectively.
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